Key Dates

Related Announcements

RFA-AI-20-026 - Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trials Not Allowed)
PAR-20-120 - Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD)
RFA-AI-20-016 - Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed)
RFA-AI-20-024 - Long Acting Treatments for HIV and HIV-Associated Co-Infections (R61/R33 Clinical Trial Not Allowed)
RFA-AI-20-010 - Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01 Clinical Trial Not Allowed)
PAR-20-106 - Centers for AIDS Research (P30 Clinical Trial Not Allowed)
PAR-20-107 - Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)
RFA-AI-20-015 - Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33 Clinical Trial Not Allowed)
RFA-AI-20-023 - Limited Competition: International Epidemiology Databases to Evaluate AIDS (IeDEA) (U01 Clinical Trial Not Allowed)
RFA-AI-20-007 - Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

NIAID will accommodate the late submission of applications submitted to NIAID-specific FOAs with receipt dates in July and August 2020 (see list below). Institutions do not need to request advance permission. Providing a cover letter that references this Notice is helpful but not required. Applications will not be accepted beyond the Late Applications Accepted Through dates indicated below at 5 PM local time.

Inquiries

Please direct all inquiries to:

The Scientific/Research Contact(s) listed in the individual funding opportunity announcements.